Correction: Notification of Major Interests

RNS Number : 3525Q
Futura Medical PLC
28 November 2016
 

The following amendment has been made to the Notification of Major Interest in Shares announcement released on 28 November 2016 at 12:00 under RNS No 3164Q.

The chain of controlled undertakings detailed in Section 9 has been corrected.

All other details remain unchanged. The full amended text is shown below.

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:

Futura Medical plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights


An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


An event changing the breakdown of voting rights

       X

Other (please specify):

Aggregation of holdings


3. Full name of person(s) subject to the
notification obligation:

R.A. Lamb

4. Full name of shareholder(s)
 (if different from 3.):

-

5. Date of the transaction and date on
which the threshold is crossed or
reached:

22/11/16

6. Date on which issuer notified:

28/11/16

7. Threshold(s) that is/are crossed or
reached:

8%



 

8. Notified details:

A: Voting rights attached to shares

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights

Direct

Indirect

Direct

Indirect

Direct

Indirect

 

Ordinary Shares

 

GB0033278473

8,779,110

8,779,110

5,330,400

3,448,710

5,330,400

3,448,710

4.44%

2.87%



B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date

Exercise/
Conversion Period

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights

n/a

n/a

n/a

n/a

n/a


C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date

Exercise/
Conversion period

Number of voting rights instrument refers to

 

% of voting rights

 






Nominal

Delta




Total (A+B+C)

Number of voting rights

Percentage of voting rights

8,779,110

7.31%



 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:

R. A Lamb

5,330,400

4.44%




Shares held by others but connected to R. A Lamb

3,448,710

2.87%


Proxy Voting:

10. Name of the proxy holder:

n/a

11. Number of voting rights proxy holder will cease to hold:

n/a

12. Date on which proxy holder will cease to hold voting rights:

n/a



13. Additional information:



14. Contact name:

Derek Martin

15. Contact telephone number:

01483 685670

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUWABRNVAAUAA
UK 100

Latest directors dealings